The current financial score of Petmed Express Inc is 6.76. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 41.02M, representing a year-over-year decrease of 19.86%, while its net profit experienced a year-over-year decrease of 82.01%.
The current valuation score of Petmed Express Inc is 8.28. Its current P/E ratio is -0.50, which is -72707.31% below the recent high of 361.37 and -69742.70% above the recent low of -347.61.
The current earnings forecast score of Petmed Express Inc is 4.00. The average price target is 2.15, with a high of 2.15 and a low of 2.15.
The current price momentum score of Petmed Express Inc is 3.90. Currently, the stock price is trading between the resistance level at 1.80 and the support level at 1.43, making it suitable for range-bound swing trading.
The current institutional shareholding score of Petmed Express Inc is 3.00. The latest institutional shareholding proportion is 41.08%, representing a quarter-over-quarter increase of 10.14%. The largest institutional shareholder is James Simons, holding a total of 1.13M shares, representing 0.00% of shares outstanding, with 63.19% decrease in holdings.
The current risk assessment score of Petmed Express Inc is 3.05. The company's beta value is 0.79. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.